UnitedHealth Group's Q4 earnings call revealed strong performance, with adjusted EPS growing 17% to $15.11 for the full year. The company's diversified businesses, including Medicare, care delivery, and pharmacy care services, drove revenue growth of $16 billion over 2018. Management expressed confidence in their outlook for 2020, reaffirming guidance and expecting revenue to approach $262 billion. The company's focus on driving affordability, innovating with consumer-centric products and services, and improving operating performance positions them well for long-term growth.

[2]